CA
REGN icon

CoreCap Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

CoreCap Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$189K Sell
249
-66
-21% -$49.9K 0.01% 860
2026
Q2 		$197K Sell
315
-97
-24% -$66K 0.01% 868
2026
Q1 		$318K Sell
412
-383
-48% -$293K 0.01% 636
2025
Q4 		$614K Buy
795
+557
+234% +$378K 0.02% 470
2025
Q3 		$134K Buy
238
+20
+9% +$11.3K ﹤0.01% 940
2025
Q2 		$114K Sell
218
-19
-8% -$10.6K ﹤0.01% 939
2025
Q1 		$150K Sell
237
-29
-11% -$19.9K 0.01% 759
2024
Q4 		$189K Sell
266
-2,663
-91% -$2.23M 0.01% 722
2024
Q3 		$3.08M Buy
2,929
+2,616
+836% +$2.91M 0.14% 148
2024
Q2 		$329K Sell
313
-77
-20% -$74.6K 0.03% 291
2024
Q1 		$375K Sell
390
-1,274
-77% -$1.21M 0.02% 451
2023
Q4 		$1.46M Buy
1,664
+1,412
+560% +$1.16M 0.09% 202
2023
Q3 		$207K Sell
252
-30
-11% -$23.6K 0.01% 500
2023
Q2 		$203K Buy
+282
New +$217K 0.01% 533
2022
Q4 		$421K Buy
583
+212
+57% +$156K 0.03% 385
2022
Q3 		$256K Sell
371
-2,209
-86% -$1.39M 0.02% 441
2022
Q2 		$1.52M Buy
+2,580
New +$1.68M 0.12% 136
2022
Q1 		– Sell
-229
Closed -$145K – 1722
2021
Q4 		$145K Buy
+229
New +$141K 0.01% 624

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

CoreCap Advisors's REGN Position: Q3 2026 in Review

CoreCap Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 21% in Q3 2026, selling an estimated $49.9K and leaving 249 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #860.

CoreCap Advisors first reported a position in REGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.08M in Q3 2024. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • CoreCap Advisors held 249 shares of Regeneron Pharmaceuticals worth $189K as of Q3 2026.
  • CoreCap Advisors sold 66 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $49.9K.
  • Regeneron Pharmaceuticals made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #860 holding.
  • CoreCap Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • CoreCap Advisors's Regeneron Pharmaceuticals position peaked at $3.08M in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.